VISION

Inspiring transformational change in the

field of oncology diagnostics

MISSION

To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies


Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.

Latest News

@ArquerDx

- 7 hours ago

What better time to refresh your knowledge of the signs and symptoms of #bladdercancer than during Bladder Cancer… https://t.co/Dxae8UA0Xy
@ArquerDx

- 1 day ago

As a #cancer sufferer, there is a lot of pressure to remain positive throughout diagnosis and treatment, but don't… https://t.co/RoviH5qjvI
@ArquerDx

- 2 days ago

Are you following our friends at @BladderCancerUK on Twitter? This is the best way to keep up to date with their cu… https://t.co/m29joemNFh